Star Lake Bioscience outlines plan for growth and shareholder returns

Star Lake Bioscience announced its 2025 "quality improvement, efficiency enhancement, and return optimization" action plan, focusing on core business growth in animal nutrition, food flavoring, and value chain extension. The company plans to strengthen existing segments, pursue breakthroughs in bio-pharmaceuticals, human nutrition, and plant nutrition, and explore new technologies. Key projects include a RMB 3.712 bn investment in Xinjiang for corn deep processing and a RMB 3.3 bn project in Heilongjiang for amino acids, aimed at enhancing product capacity and market share.

The company prioritizes robust shareholder returns, proposing a 2025-2027 shareholder return plan that includes annual cash dividends of RMB 3.80 per 10 shares on a total share capital of 1,661,472,616 shares, resulting in an annual distribution of RMB 631,359,600. This follows similar distributions in 2023 and 2024. The plan outlines conditions for cash and stock dividends, prioritizing cash, and aims for at least 30% of average distributable profits over three years to be returned as cash.

In line with this, the company will hold its second extraordinary general meeting of 2025 on September 15, 2025, to approve revisions to its articles of association and other governance documents. These changes will bolster corporate governance and ensure compliance with regulatory standards, including a commitment to continuous R&D innovation for sustainable development.